Kai Rejeski

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Kai Rejeski
Apr 27, 2025, 09:30 | Science
Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
MSK Department of Medicine shared an article by Kai Rejeski et al. on X: "Congrats…
Apr 20, 2025, 09:28 | Science
Khushali Jhaveri: A lesser-known vulnerability in CAR T-cell therapy - Sarcopenia
Khushali Jhaveri, Haematology-Oncology Fellow at Moffitt Cancer Centre, shared an article on X: "Hot off the…
Apr 17, 2025, 09:48 | Science
Roni Shouval: CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
Roni Shouval, Assistant Attending of Bone Marrow Transplantation and Cellular Therapy Service and Principal Investigator…
Feb 7, 2025, 13:15 | Blog
Roni Shouval: Treatment failure patterns in early vs late introduction of CAR T-cell therapy in large B-cell lymphoma
Roni Shouval, Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on X:…
Jan 15, 2025, 14:01 | Science
Kai Rejeski: Delineating the prognostic significance of immune reconstitution in CAR-T recipients
Kai Rejeski, Research Fellow at Memorial Sloan Kettering Cancer Center, shared an article by Sophia…
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 11, 2024, 09:23 | Insight
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…
Aug 3, 2024, 09:33 | Blog
Nonrelapse mortality after CAR T cell therapy by Dr. Kai Rejeski - IACH
The International Academy for Clinical Hematology shared a post on X: "Hear the latest at The…
Jul 24, 2024, 08:12 | Insight
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…
Jul 14, 2024, 01:25 | Insight
Piotr Wysocki: Nonrelapse mortality in CAR-T-treated patients. Beware of infections!
Piotr Wysocki recently posted on LinkedIn: "Cordas DM et al. conducted a systematic review and meta-analysis…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 9, 2024, 06:46 | Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jun 20, 2024, 13:09 | Blog
Sophia Stock: Our work on immune reconstitution after CAR-T at EHA2024
Sophia Stock, Clinician Scientist at LMU Munich Hospital, shared a post on X: “Heading home…
May 9, 2024, 10:46 | Insight
Kai Rejeski: All that we currently know and understand about CAR-T related cytopenias
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: "Check out…
Apr 26, 2024, 20:41 | Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
Apr 13, 2024, 10:00 | Blog
Kai Rejeski: The clinical impact of the new European Hematology Association The EBMT grading of immune effector cell-associated hematotoxicity
Kai Rejeski, Postdoctoral Researcher at the Gene Center, Ludwig-Maximilians-University, shared a post on X: "Great to see this out…
All: 18 Posts: 1 - 100
Special Coverage